Literature DB >> 12933942

Physical anhedonia in Parkinson's disease.

V Isella1, S Iurlaro, R Piolti, C Ferrarese, L Frattola, I Appollonio, P Melzi, M Grimaldi.   

Abstract

Anhedonia is the inability to experience physical or social pleasure. Its physical component is hypothesised to be due to dysfunction of a dopaminergic frontotemporal-subcortical circuit and has never been investigated as a possible affective complication of Parkinson's disease (PD). The aim of this study was to formally assess prevalence and correlates of physical anhedonia in PD patients compared with normal controls. Twenty five people with PD and 25 matched controls were administered a psychometric battery exploring mainly executive functions and mood. Hedonic tone was assessed using Chapman's Physical Anhedonia Scale. PD patients also underwent MRI linear measurement of frontal structures. Anhedonia levels were significantly higher in PD patients with respect to controls, although not extremely elevated; prevalence rate was 40% for parkinsonians, while no anhedonics were found among controls. Clinical, neuropsychological, and quantitative neuroradiological features did not show any significant correlation with physical anhedonia. Physical anhedonia appears to be a relatively frequent, although mild, affective disturbance of PD, independent from neurological, frontal, and depressive aspects.

Entities:  

Mesh:

Year:  2003        PMID: 12933942      PMCID: PMC1738679          DOI: 10.1136/jnnp.74.9.1308

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  25 in total

1.  Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory.

Authors:  Anita J Bechtholt-Gompf; Hali V Walther; Martha A Adams; William A Carlezon; Dost Ongür; Bruce M Cohen
Journal:  Neuropsychopharmacology       Date:  2010-06-09       Impact factor: 7.853

Review 2.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

Review 3.  Translational Assessment of Reward and Motivational Deficits in Psychiatric Disorders.

Authors:  Andre Der-Avakian; Samuel A Barnes; Athina Markou; Diego A Pizzagalli
Journal:  Curr Top Behav Neurosci       Date:  2016

4.  Relationship between depression and cognitive dysfunctions in Parkinson's disease without dementia.

Authors:  Gabriella Santangelo; Carmine Vitale; Luigi Trojano; Katia Longo; Autilia Cozzolino; Dario Grossi; Paolo Barone
Journal:  J Neurol       Date:  2009-04-15       Impact factor: 4.849

5.  [Practical experience on improving activities of daily living competence in Parkinson's patients treated with ropinirole. Results of a applied study].

Authors:  H Reichmann; D Angersbach; B Buchwald
Journal:  Nervenarzt       Date:  2005-10       Impact factor: 1.214

Review 6.  Neural stem cells in Parkinson's disease: a role for neurogenesis defects in onset and progression.

Authors:  Jaclyn Nicole Le Grand; Laura Gonzalez-Cano; Maria Angeliki Pavlou; Jens C Schwamborn
Journal:  Cell Mol Life Sci       Date:  2014-11-18       Impact factor: 9.261

7.  Taste responses in patients with Parkinson's disease.

Authors:  H Sienkiewicz-Jarosz; A Scinska; W Kuran; D Ryglewicz; A Rogowski; E Wrobel; A Korkosz; A Kukwa; W Kostowski; P Bienkowski
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-01       Impact factor: 10.154

Review 8.  The neurobiology of anhedonia and other reward-related deficits.

Authors:  Andre Der-Avakian; Athina Markou
Journal:  Trends Neurosci       Date:  2011-12-15       Impact factor: 13.837

9.  How groove in music affects gait.

Authors:  Li-Ann Leow; Sarah Watson; David Prete; Kristina Waclawik; Jessica A Grahn
Journal:  Exp Brain Res       Date:  2021-06-09       Impact factor: 1.972

10.  Atrophy of basal ganglia nuclei and negative symptoms in temporal lobe epilepsy.

Authors:  Elizabeth K Geary; Michael Seidenberg; Bruce Hermann
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.